Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?
COVID-19
breast
cancer
reconstruction
Journal
Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236
Informations de publication
Date de publication:
2020
2020
Historique:
received:
17
04
2020
entrez:
23
6
2020
pubmed:
23
6
2020
medline:
23
6
2020
Statut:
epublish
Résumé
The onset of the COVID-19 pandemic has changed the face of the treatment of breast cancer and breast reconstruction globally. Mastectomy with immediate implant-based breast reconstruction was on the rise due to advances in meshes and implants. However, due to the prioritisation of the critically ill and diversion of the work force, breast cancer treatment has drastically changed. This is an opinion paper written by the authors with experience and importance in the scenario of breast reconstructive surgery. The authors are from different countries with the COVID-19 pandemic in different stages.
Identifiants
pubmed: 32565894
doi: 10.3332/ecancer.2020.1041
pii: can-14-1041
pmc: PMC7289604
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1041Informations de copyright
© the authors; licensee ecancermedicalscience.
Déclaration de conflit d'intérêts
Hilton Becker is a consultant for Mentor Corp. All of the other authors have no conflicts of interest to declare.
Références
Br J Surg. 2000 Nov;87(11):1455-72
pubmed: 11091232
Eur J Surg Oncol. 2000 Feb;26(1):17-9
pubmed: 10718173
J Clin Oncol. 2014 Mar 20;32(9):919-26
pubmed: 24550418
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Plast Reconstr Surg. 2013 Jan;131(1):15-23
pubmed: 23271515